Research news
We’ve awarded Cellestial Health £55,000 to continue exploring networks of brain cells that may hold answers for new treatments for Parkinson’s.
Thanks to our crucial funding, a new drug treatment, created by NRG Therapeutics, is moving forwards.
Results from 3 recent studies show that people from South Asian and Black backgrounds are less likely to receive timely access to Parkinson’s care, support and research opportunities.
Tech Guide, our online platform to help people make informed decisions about technology, has been recognised at the Made with Patient awards.
11 people have received the treatment which aims to boost brain cells’ ability to repair themselves.
A clinical trial for people with a sleep disorder who are at higher risk of developing Parkinson’s has begun in Oxfordshire.
Results from a Parkinson’s UK funded study showed the app could help improve many aspects of mental health. The app is available now and free to download.
Two separate research studies have both shown promising early results for a treatment that aims to replace brain cells that are lost in Parkinson’s.
We’ve awarded Pretzel Therapeutics £200,000 to investigate a new drug which could prevent cells from dying in Parkinson’s.
In our latest round of grants we’ve awarded funding for new projects that aim to improve symptoms of Parkinson’s without the need for extra medication.